COBAS 4800 HPV TEST 05235910190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2017-03-31 for COBAS 4800 HPV TEST 05235910190 manufactured by Roche Molecular Systems.

Event Text Entries

[71463770] The investigation into the case issue is on-going. A supplementation report will be provided at the end of the investigation. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[71463771] (b)(6) customer reported the generation of discrepant (b)(6) results for a patient between the cobas 4800 hpv test ((b)(6)) and other tests ((b)(6)). Samples (different collections) were tested for the same patient in (b)(6) 2015 and (b)(6) 2016. All results generated with the cobas 4800 hpv test were (b)(6), ((b)(6) 2016). Recent testing ((b)(6) 2016) using other tests (seegene anyplex ii hpv28 test; genxpert hpv test; "in-house" protocol) generated (b)(6) results. A biopsy from (b)(6) 2016 showed high-grade squamous intraepithelial lesion (hsil) and squamous cell cancer. It is not known if the patient had cancer in (b)(6) 2015, when she was originally tested (b)(6) with the cobas 4800 hpv test. Roche has requested remaining sample to perform further analysis.
Patient Sequence No: 1, Text Type: D, B5


[75940312] A (b)(6) customer reported the generation of discrepant (b)(6) results for a patient between the cobas 4800 hpv test (b)(6) and other tests (b)(6). A biopsy from (b)(6) 2016 showed high-grade squamous intraepithelial lesion (hsil) and squamous cell cancer. The sample from (b)(6) 2016 was sent to roche for sequencing analysis. The sample was subjected to sequencing using all pgmy primers and (b)(6) type 16 specific primers. Pgmy would confirm the presence of (b)(6) in the sample while the type specific primers would generate sequence information under the assay oligos binding sites. Different volume inputs, number of cycles were tested to increase the probability of obtaining the targeted amplicon. Despite several attempts to obtain (b)(6) sequences from the samples, no viral sequences were obtained. The lack of (b)(6) sequence does not necessarily mean that no (b)(6) was present in the samples. The lack of sequence information could be due to inhibitory factors that have a (b)(6) impact to the cobas hpv assay performance or the sequence heterogeneity affecting the primers used for sequencing. From the internal investigation performed on the product, no related issues to the customer allegation were identified. After filing the initial mdr report, information was provided, specifically relating to the patient and the initial reporter. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2017-00007
MDR Report Key6450462
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2017-03-31
Date of Report2017-05-16
Date of Event2017-03-06
Date Mfgr Received2017-03-06
Date Added to Maude2017-03-31
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA STACIE-ANN CREIGHTON
Manufacturer Street1080 US HWY 202 S NA
Manufacturer CityBRANCHBURG NJ 08876
Manufacturer CountryUS
Manufacturer Postal08876
Manufacturer Phone9082537112
Manufacturer G1NA
Manufacturer StreetNA NA
Manufacturer CityNA
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameCOBAS 4800 HPV TEST
Generic NameKIT, DNA DETECTION, HUMAN PAPILLOMAVIRUS
Product CodeMAQ
Date Received2017-03-31
Model NumberNA
Catalog Number05235910190
Lot NumberX08046
ID NumberNA
Device Expiration Date2018-08-31
OperatorHEALTH PROFESSIONAL
Device Availability*
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HIGHWAY 202 SOUTH NA BRANCHBURG NJ 08869 US 08869


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2017-03-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.